Markets
FRANCE-ECONOMY-PHARMACEUTICAL-INDUSTRY
(Frederick Florin/Getty Images)

Pharma stocks sink on threats that they won’t be spared from tariffs much longer

President Trump said he would impose tariffs on pharmaceuticals, then he didn’t, and now he said he will. Investors are queasy.

4/9/25 8:05AM

Pharmaceutical stocks are dipping after President Trump suggested they won’t be spared by tariffs for much longer.

Drugmakers were spared from the first round of tariffs that went into effect on Wednesday, despite Trump consistently saying the industry was a priority. Pharmaceutical products are normally excluded from tariffs under a World Trade Organization agreement that the US signed in 1994.

But speaking at a dinner for the National Republican Congressional Committee on Tuesday evening, Trump told a crowd of lawmakers that pharmaceuticals will soon be hit with “major” tariffs. Companies like Pfizer, Eli Lilly, and Johnson & Johnson sank in premarket trading.

“When they hear that, they will leave China,” he said. “They will leave other places because they have to sell — most of their product is sold here and they’re going to be opening up their plants all over the place.”

Though the president’s comments focused on China, the companies most likely to reshore any operations to the US are the aforementioned European drugmakers. They tend to produce research-based name-brand drugs that carry high margins in the US. Bloomberg reported yesterday that European drugmakers are asking the bloc for some favors to convince them not to jump ship and move to the US.

Generic drugs, on the other hand, tend to be imported from India, where labor is cheap. Since the margins are so thin on those drugs, generic drugmakers said they don’t have many levers to pull besides raising prices. Active pharmaceutical ingredients, the chemical components within those finished medicines, predominantly come from China.

Pharmaceutical goods have generally been excluded from the tariffs imposed on China that started in 2018.

Just last week, the initial wave of tariffs briefly worried industry onlookers (myself included!) only for those concerns to be dismissed as premature. After all, what kind of fool anticipates that tariffs on pharmaceuticals would happen when the administration said they would?

More Markets

See all Markets
markets

Warner Bros. Discovery jumps after Wells Fargo ups price target on dealmaking buzz

Warner Bros. Discovery shares popped 7% Tuesday after Wells Fargo raised its price target on the media giant to $14 from $13 while keeping an equal-weight rating.

The bank’s optimism stemmed largely from the media giant’s potential for dealmaking. In June, WBD announced that it would split its operations into two companies, with the Streaming & Studios division (home to Warner Bros. Television, DC Studios, HBO, and Max) standing alone from the networks side (CNN, TNT Sports, and Discovery).

That separation could make the Streaming & Studios unit more attractive to buyers, the analysts said. They valued the segment at about $65 billion, which could translate to a takeover price north of $21 a share. Potential suitors range from Amazon and Apple to Sony and Comcast, though analysts flagged Netflix as the “most compelling” option despite its limited acquisition track record:

“While NFLX has historically not been acquisitive, [streaming and studios’] $12bn in annual content spend + library + 100+ acre studio lot offers a lot. It kickstarts a theatrical IP strategy, quickly scales video games and most importantly provides premium content to members.”

At Goldman Sachs’ Communacopia + Technology Conference this week, CEO David Zaslav also highlighted growing traction at HBO Max and hinted at future crackdowns on password sharing.

WBD shares are up 26% year to date, and up more than 93% over the past 12 months.

markets

Duolingo up on bullish note, hopes for a user rebound

Duolingo rose by the most in nearly a month after an analyst note painted a more bullish picture of the gamified language-learning company despite a dearth of news otherwise.

A quick check-in with analysts covering the stock on Wall Street found most of them otherwise flummoxed on the reason behind the uptick Thursday.

Some, however, suggested the rise may reflect optimism that the company has been able to reverse a monthslong downturn in daily active user metrics — a slump that set in after a social media backlash to a somewhat artless LinkedIn post from the company about its AI first strategy.

The bullish analyst note, published Thursday by Citizens JMP, suggested Duolingo could be a big beneficiary from a change to Apple’s rules governing its App Store driven by a ruling on a federal antitrust case against the company. The analysts wrote:

Given “Apple’s recent changes to U.S. App Store rules that allow developers to steer payments to the web where fees are similar to typical credit card fees rather than Apple’s 30% fee for in-app purchases and 30% fee on subscriptions for the first year and 15% thereafter, we expect mobile app companies including Duolingo, Life360, and Grindr Inc. to unlock meaningful cost benefits.”

At any rate, the next big event on the company’s calendar is its Duocon 2025 conference on Tuesday, where analysts are hoping to hear more hard information on all of the above topics.

markets

Jeep maker Stellantis surges as CEO says the automaker is in productive tariff talks with the US

Shares of Jeep and Dodge maker Stellantis are up more than 8% in Thursday afternoon trading, following comments from the automaker’s new CEO, Antonio Filosa, at a European auto conference.

On tariffs, Filosa said that Stellantis has had a “very productive exchange of ideas” with the Trump administration on the company’s manufacturing footprint and that the environment around the levies is “getting clearer and clearer.”

The US is Stellantis’ top priority, according to Filosa, and the company has taken efforts to turn things around in the market, where its struggled with sales in recent years. To fuel the turnaround, Stellantis is bringing back its popular Jeep Cherokee, which it discontinued in 2023.

As of 12:45 p.m. ET, Stellantis’ trading volume was at more than 140% of its average over the past 30 days.

Latest Stories

Sherwood Media, LLC produces fresh and unique perspectives on topical financial news and is a fully owned subsidiary of Robinhood Markets, Inc., and any views expressed here do not necessarily reflect the views of any other Robinhood affiliate, including Robinhood Markets, Inc., Robinhood Financial LLC, Robinhood Securities, LLC, Robinhood Crypto, LLC, or Robinhood Money, LLC.